Greater Copenhagen Microbiome Signature Project
The Greater Copenhagen region, which spans eastern Denmark and southern Sweden, is home to 4.3 million inhabitants. With 42,500 employees in the life science industry and 14,600 university researchers spread across nine universities based in the region, Medicon Valley is the strongest life science cluster in the Nordics.
This project seeks to build on the Medicon Valley cluster’s strengths by positioning it as a global centre for microbiome research. It is a three-year project (2019-2022) financed by Interreg Öresund-Kattegat-Skagerrak and is jointly led by Copenhagen Capacity, Invest in Skåne and Medicon Valley Alliance.
The project aims to strengthen entry into the Greater Copenhagen region’s research environment within microbiome research through enhancing collaboration and synergies cross border and cross disciplines. It also seeks to boost private investments in research and innovation, through establishing international research facilities and activities, as well as attracting talent to both publicly and privately funded research environments.
Microbiome research is expanding in Greater Copenhagen with companies like, Biogaia, Chr. Hansen, Ferring, Novozymes, Probi and SNIPR BIOME investing in its continuous development. Microbiome research is also being investigated by the academic world with both Copenhagen University, Lund University and The Technical University of Denmark researching how microbiome influences illnesses such as asthma, diarrhea and obesity and how microbiome can help women’s health or improve food security of aid in sustainable food production.
Find out why Medicon Valley is a global centre for microbiome research
